Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid-sparing Regimen With Olanzapine and Ondansetron to Prevent Emesis Caused by High Dose Cisplatin
NCT07699276Phase 2Recruiting
- Sponsor
- Mahidol University
- Start
- Feb 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 2 trial of olanzapine, palonosetron in chemotherapy-induced nausea and vomiting (CINV), sponsored by Mahidol University. Started Feb 2026; status: recruiting.
02
Drugs
olanzapinepalonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT07699276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07699276.